Breaking News - The Fly

Open Search

OLMA

Olema Oncology

$

()

Olema Oncology initiated with bullish view at Goldman Sachs, here's why

OLMA

4/2/2024 - 04:57am

Olema Oncology reports Q4 EPS (49c), consensus (48c)

OLMA

3/11/2024 - 16:06pm

Olema Oncology announces publication of data on palazestrant

OLMA

3/6/2024 - 07:09am

Olema Oncology files to sell 13.21M shares of common stock for holders

OLMA

1/31/2024 - 16:24pm

Olema Oncology initiated with bullish view at Citi, here's why

OLMA

1/30/2024 - 05:04am

Olema Oncology nominates OP-3136 as development candidate

OLMA

1/8/2024 - 08:37am

Olema Oncology announces interim results from Phase 1b/2 study of palazestrant

OLMA

12/5/2023 - 12:30pm

Olema Oncology to present new Palazestrant clinical data at SABCS

OLMA

11/28/2023 - 17:19pm

Olema Oncology price target lowered to $28 from $29 at JPMorgan

OLMA

11/22/2023 - 06:08am

Olema Oncology reports Q3 EPS (48c), consensus (51c)

OLMA

11/7/2023 - 16:34pm

Olema Oncology price target raised to $25 from $19 at JPMorgan

OLMA

10/24/2023 - 07:16am

Olema Oncology price target raised to $22 from $16 at Canaccord

OLMA

10/24/2023 - 06:22am

Olema Oncology breast cancer data a 'home run,' says H.C. Wainwright

OLMA

10/23/2023 - 12:17pm

Olema Oncology: Median PFS was 4.6 months in Phase 2 palazestrant study

OLMA

10/23/2023 - 12:16pm

Olema Oncology appoints Garland to board of directors

OLMA

10/17/2023 - 07:16am